4506 — Sumitomo Pharma Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Sumitomo Pharma Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	35,918	36,829	40,600	-96,714	-314,929
Depreciation
Non-Cash Items	28,869	52,197	49,850	87,168	118,520
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-36,024	23,902	-97,559	-20,915	-82,114
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	46,128	135,601	31,239	10,802	-240,758
Capital Expenditures	-13,351	-10,806	-13,494	-12,742	-15,730
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-299,333	19,681	-4,784	65,161	48,766
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-312,684	8,875	-18,278	52,419	33,036
Financing Cash Flow Items	-1,353	-17,335	-870	-197,436	659
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	231,081	-57,215	-21,426	-146,817	77,851
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-35,588	91,990	9,286	-59,506	-114,431